Chief Scientific Off,SVP-R&D of Cara Therapeutics, Inc. (NASDAQ:CARA), Menzaghi Frederique Ph.D., sells 2,812 shares worth $43,024
According to Cara Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 30 06:15 PM, company Chief Scientific Off,SVP-R&D, Menzaghi Frederique Ph.D. disclosed selling 2,812 shares at a cost of $15.30. At the time of this transaction (Dec 30), this trade was worth $43,024 in total. As of Dec 30, Menzaghi Frederique Ph.D. now owns 109,680 shares in total worth about $1,686,878.4000000001.
For the last few recent trades made by Cara Therapeutics, Inc. (NASDAQ:CARA) Chief Scientific Off,SVP-R&D, Menzaghi Frederique Ph.D., we have the following information:
- SEC Form 4 filing: Apr 21: Sold 12,894 shares at the rate of $15.58 per share. Total worth of this trade was $200,889. Total number of shares owned as of Apr 21 were 104,492
- SEC Form 4 filing: Oct 25: Sold 4,000 shares at the rate of $19.91 per share. Total worth of this trade was $79,640. Total number of shares owned as of Oct 25 were 63,886
- SEC Form 4 filing: Oct 18: Sold 4,000 shares at the rate of $19.33 per share. Total worth of this trade was $77,320. Total number of shares owned as of Oct 18 were 67,886
Posted by
George Daniels
on Wednesday December 30 2020, 9:54 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
